Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price

AMEX: CANF
$1.68
+0.00 (0.00%) Last updated on 29 Oct, 2026 | 23:46 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Stock Performance

Open
$1.70
Prev. Close
$1.68
Circuit Range
N/A
Day Range
$1.66 - $1.70
Year Range
$0.17 - $10.39
Volume
331
Average Traded
$1.68

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price Today

As of 30 October 2026, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)'s share price is $1.68. The stock opened at $1.70, compared to its previous close of $1.68. During today's trading session, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)'s share price traded between $1.66 and $1.70, with an average price of $1.68. Over the past 52 weeks, the stock has recorded a high of $10.39 and a low of $0.17. In terms of performance, Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)'s share price has declined by 46.67% over the last six months and is up 300.95% on a year-on-year basis.

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Share Price Chart

Line chart of the Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) price trend over the selected period. The price rose overall, ranging from 1.66 to 1.70, ending at 1.68.
$1.66$1.70
L
Show Current Price
H

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
N/A
Return On Equity (TTM)
N/A
Profit Margin
N/A
Debt to Equity
N/A
Quarterly Earnings Growth YoY
N/A

About Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2)

Can Fite Biopharma Ltd is a clinical-stage biopharmaceutical company. The company focuses on developing orally bioavailable small-molecule drugs targeting the A3 adenosine receptor for treating cancer, inflammatory diseases, liver disorders, and related conditions. It has a pipeline of proprietary drug candidates in Phase II and Phase III clinical development. The company's platform targets the A3 adenosine receptor (A3AR), which is more expressed in inflammatory and cancerous cells than in normal cells. Its pipeline drugs include Namodenoson, Piclidenoson, CF602, and Cannabinoids.

Can-Fite BioPharma Ltd. American Depositary Shares, each representing two (2) Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Oct 2026
$2.20
$1.68
-24.32%
Sep 2026
$3.20
$2.22
-35.75%
Aug 2026
$3.52
$3.46
+5.66%
Jul 2026
$4.89
$3.27
+14.34%
Jun 2026
$3.25
$2.86
-16.37%
May 2026
$3.04
$3.42
+8.57%
Apr 2026
$3.18
$3.15
+1.61%
Mar 2026
$4.83
$3.10
-35.01%
Feb 2026
$4.14
$4.77
+17.78%
Jan 2026
$0.19
$4.05
+1,935.18%
Dec 2025
$0.34
$0.20
-43.30%
Nov 2025
$0.41
$0.35
-16.23%

CANF Share Price FAQs